Intranasal cocaine: dose relationships of psychological effects and plasma levels
- PMID: 7095978
- DOI: 10.2190/5x0n-twkj-ggy6-t10n
Intranasal cocaine: dose relationships of psychological effects and plasma levels
Abstract
We compared the psychological effects of three doses of intranasal cocaine hydrochloride (.2, .75, and 1.5 mg/kg) with cocaine plasma concentrations in four volunteers. Intranasal lidocaine hydrochloride (.2 mg/kg) was used as a topically active placebo. Peak "high" ratings were related to both dose and peak plasma concentrations. At a given plasma concentration, "high" ratings were greater when plasma levels were increasing than when they were decreasing. This indicates that acute tolerance by tachphylaxis occurred after single doses. The cocaine "high" was a pleasant feeling but was without distinctive sensations. The dramatic effects of intranasal cocaine on the street may be related to larger or repeated doses as well as the setting.
Similar articles
-
Cocaine plasma concentration: relation to physiological and subjective effects in humans.Science. 1978 Oct 13;202(4364):227-8. doi: 10.1126/science.694530. Science. 1978. PMID: 694530
-
Oral cocaine: plasma concentrations and central effects.Science. 1978 Apr 14;200(4338):211-3. doi: 10.1126/science.24895. Science. 1978. PMID: 24895
-
Cocaine and lidocaine have similar psychological effects after intranasal application.Life Sci. 1979 Jan 15;24(3):271-4. doi: 10.1016/0024-3205(79)90229-7. Life Sci. 1979. PMID: 423706 Clinical Trial. No abstract available.
-
Intranasal cocaine in humans: acute tolerance, cardiovascular and subjective effects.Pharmacol Biochem Behav. 2004 May;78(1):93-101. doi: 10.1016/j.pbb.2004.02.018. Pharmacol Biochem Behav. 2004. PMID: 15159138
-
Cardiovascular effects of cocaine in humans: laboratory studies.Drug Alcohol Depend. 1995 Mar;37(3):193-210. doi: 10.1016/0376-8716(94)01085-y. Drug Alcohol Depend. 1995. PMID: 7796714 Review.
Cited by
-
Serotonergic mechanisms of cocaine effects in humans.Psychopharmacology (Berl). 1995 May;119(2):179-85. doi: 10.1007/BF02246159. Psychopharmacology (Berl). 1995. PMID: 7659765 Clinical Trial.
-
Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects.Clin Pharmacokinet. 2017 Oct;56(10):1219-1230. doi: 10.1007/s40262-017-0513-9. Clin Pharmacokinet. 2017. PMID: 28197931 Free PMC article. Clinical Trial.
-
Concurrent cocaine-ethanol ingestion in humans: pharmacology, physiology, behavior, and the role of cocaethylene.Psychopharmacology (Berl). 1993;111(1):39-46. doi: 10.1007/BF02257405. Psychopharmacology (Berl). 1993. PMID: 7870932 Clinical Trial.
-
Animal models of drug craving.Psychopharmacology (Berl). 1993;112(2-3):163-82. doi: 10.1007/BF02244907. Psychopharmacology (Berl). 1993. PMID: 7871016 Review.
-
Co-targeting the kappa opioid receptor and dopamine transporter reduces motivation to self-administer cocaine and partially reverses dopamine system dysregulation.Sci Rep. 2024 Mar 18;14(1):6509. doi: 10.1038/s41598-024-53463-9. Sci Rep. 2024. PMID: 38499566 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources